…
Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Grey Cloak Tech Inc (HYEX.US) is limited; the company is an OTCQB-listed issuer and detailed descriptions of its core business, products and markets are not available in public filings or company disclosures. Due to constrained disclosure, long-term growth drivers are unclear and investors may benefit only if management later demonstrates a clear strategy and tangible execution such as product development, revenue traction or strategic partnerships.
Material risks include very low liquidity typical of OTCQB stocks, potential equity dilution from future financings, execution risk for unproven initiatives and regulatory or compliance challenges that could materially affect prospects.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.88M | -0.84M | -2.47M | -0.98M | -1.99M |
| Net income | -0.88M | -0.84M | -2.47M | -0.98M | -1.99M |
| Selling general administrative | 3.37M | 2.09M | 3.87M | 2.28M | 2.58M |
| Gross profit | 2.42M | 1.91M | 1.62M | 1.37M | 0.70M |
| Reconciled depreciation | 0.15M | -0.00M | 0.00M | 0.00M | 0.01M |
| Ebit | - | - | - | - | -1.84M |
| Ebitda | - | - | - | -0.91M | -1.93M |
| Operating income | -0.94M | -0.18M | -2.24M | -0.91M | -1.89M |
| Interest expense | - | - | - | - | 0.05M |
| Net interest income | -0.21M | -0.19M | -0.18M | -0.06M | -0.05M |
| Total revenue | 4.51M | 3.11M | 2.49M | 2.25M | 1.47M |
| Total operating expenses | 5.46M | 3.30M | 4.73M | 3.16M | 3.35M |
| Cost of revenue | 2.09M | 1.20M | 0.86M | 0.88M | 0.77M |
| Total other income expense net | 0.27M | -0.47M | -0.05M | -0.01M | -0.05M |
| Net income from continuing ops | -0.88M | -0.84M | -2.47M | -0.98M | -1.99M |
| Net income applicable to common shares | - | - | - | -0.98M | -1.99M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 27.82M | 2.38M | 2.64M | 2.78M | 3.03M |
| Intangible assets | 0.53M | 0.52M | 0.52M | 0.52M | 0.52M |
| Other current assets | 0.00M | 0.01M | 0.07M | -0.00M | - |
| Total liab | 3.80M | 1.97M | 1.68M | 0.90M | 0.56M |
| Total stockholder equity | 24.03M | 0.41M | 0.95M | 1.88M | 2.47M |
| Other current liab | -0.00M | 0.63M | 0.15M | 0.10M | 0.09M |
| Common stock | - | - | - | - | 0.34M |
| Capital stock | 0.37M | 0.35M | 0.35M | 0.35M | 0.34M |
| Retained earnings | -20.12M | -19.24M | -18.40M | -15.93M | -14.94M |
| Good will | 21.12M | 0.19M | 0.19M | 0.19M | 0.19M |
| Other assets | - | - | - | - | -0.00M |
| Cash | 0.15M | 0.11M | 0.02M | 0.07M | 0.22M |
| Total current liabilities | 1.69M | 1.34M | 1.68M | 0.90M | 0.56M |
| Net debt | 1.98M | 0.82M | 1.03M | 0.53M | 0.12M |
| Short long term debt | 0.71M | 0.93M | 1.05M | 0.59M | 0.34M |
| Other stockholder equity | - | - | - | 0.00M | - |
| Property plant equipment | - | - | - | - | 0.00M |
| Total current assets | 1.33M | 1.66M | 1.90M | 1.99M | 2.31M |
| Net tangible assets | - | - | - | - | 1.76M |
| Net receivables | 0.19M | 0.01M | 0.03M | 0.11M | 0.13M |
| Long term debt | 1.41M | 0.00M | - | - | - |
| Inventory | 0.84M | 1.36M | 1.63M | 1.82M | 1.96M |
| Accounts payable | 0.11M | 0.05M | 0.12M | 0.09M | 0.04M |
| Non currrent assets other | -0.00M | - | -0.00M | -0.00M | -0.00M |
| Non current assets total | 26.50M | 0.72M | 0.74M | 0.79M | 0.72M |
| Capital lease obligations | 0.52M | 0.01M | 0.07M | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.00M | 0.00M | -0.01M | -0.10M |
| Change to liabilities | - | - | - | 0.00M | -0.03M |
| Total cashflows from investing activities | - | - | - | -0.01M | -0.10M |
| Net borrowings | -0.19M | -0.18M | 0.39M | - | 0.17M |
| Total cash from financing activities | -0.19M | -0.19M | 0.37M | 0.19M | 1.16M |
| Change to operating activities | - | - | - | - | 0.07M |
| Net income | -0.88M | -0.84M | -2.47M | -0.98M | -1.99M |
| Change in cash | 0.03M | 0.09M | -0.05M | -0.16M | 0.16M |
| Begin period cash flow | 0.11M | 0.02M | 0.07M | 0.22M | 0.06M |
| End period cash flow | 0.15M | 0.11M | 0.02M | 0.07M | 0.22M |
| Total cash from operating activities | 0.17M | 0.28M | -0.42M | -0.33M | -0.90M |
| Issuance of capital stock | - | - | - | - | 1.00M |
| Depreciation | 0.15M | -0.00M | 0.00M | 0.00M | 0.01M |
| Change to inventory | 0.55M | 0.27M | 0.19M | 0.14M | 0.46M |
| Change to account receivables | -0.14M | 0.02M | 0.08M | 0.03M | -0.12M |
| Sale purchase of stock | 0.00M | -0.01M | -0.09M | -0.01M | - |
| Other cashflows from financing activities | - | - | - | -0.06M | -0.06M |
| Change to netincome | - | - | - | 0.41M | 0.69M |
| Capital expenditures | 0.02M | 0.00M | 0.00M | 0.01M | 0.01M |
| Change in working capital | 0.43M | 0.31M | 0.36M | 0.23M | 0.39M |
| Stock based compensation | - | - | - | 0.00M | 0.00M |
| Other non cash items | 0.42M | 0.04M | 0.00M | -0.00M | - |
| Free cash flow | 0.15M | 0.28M | -0.42M | -0.34M | -1.00M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HYEX Grey Cloak Tech Inc |
- -% |
1.35 | - | - | 2.11 | 0.59 | 3.52 | 110.69 |
| MKKGY Merck KGaA ADR |
0.45 1.38% |
33.07 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
2.27 1.38% |
167.12 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.31 1.47% |
21.43 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
43.15 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States. It operates through Corporate and Health Supplements segments. The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health. It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is headquartered in Henderson, Nevada.
7375 Commercial Way, Henderson, NV, United States, 89011
720 463 1004
22
| Name | Title | Year Born |
|---|---|---|
| Mr. Kevin Pitts | CEO, Pres, Treasurer & Director | 1960 |
| Mr. Robert Madden | CFO & Sec. | 1972 |
| Mr. J. Scott Landers | Exec. VP of Sales & Marketing | NA |
| Mr. Donald Swanson | CEO & Chairman | 1959 |
| Mr. Kevin Pitts | President, COO, Treasurer & Director | 1960 |
| Mr. Robert Madden | CFO & Secretary | 1972 |
| Mr. J. Scott Landers | Executive Vice President of Sales & Marketing | NA |
| Mr. Aaron Hefter | Chief Brand Officer | 1981 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.